Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02504827 · ClinicalTrials.gov registry record · Phase 4
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
A Phase 4 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT02504827 is a Phase 4 study that has completed, run by University of Southern California. The registered enrollment target is 12 participants.
The verdict
NCT02504827, a Phase 4 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to characterize the pharmacokinetics of intravenous ceftazidime/avibactam in patients with Cystic Fibrosis.
Interventions
- DRUG Ceftazidime/avibactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02504827
The ClinicalTrials.gov registry entry for NCT02504827 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceftazidime/avibactam is the first listed.
NCT02504827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02504827 about?
NCT02504827 is a clinical study titled "Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis". The purpose of this research study is to characterize the pharmacokinetics of intravenous ceftazidime/avibactam in patients with Cystic Fibrosis.
What is the current status of trial NCT02504827?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2015-09. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02504827?
The interventions under investigation include: Ceftazidime/avibactam (DRUG).
Who is sponsoring clinical trial NCT02504827?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.